awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41386664-D6552D0A-396A-4EDB-B662-4057915CEAC4
Q41386664-D6552D0A-396A-4EDB-B662-4057915CEAC4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41386664-D6552D0A-396A-4EDB-B662-4057915CEAC4
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.
P2093
Q41386664-D6552D0A-396A-4EDB-B662-4057915CEAC4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41386664-D6552D0A-396A-4EDB-B662-4057915CEAC4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
80010b3a2d7be4b4b250900102dbb38e12bd458a
P1545
8
http://www.w3.org/2001/XMLSchema#string
P2093
Claudio Solaro
http://www.w3.org/2001/XMLSchema#string